Jason Amello, Corporate Contrllr, Chief Accnt Officr at GENZYME CORP (GENZ), sold 6,640 shares at $70.30 ($467K) on 2010-08-31, disclosed to the SEC on 2010-09-02.
Open-market sale of $467k GENZ by Corporate Contrllr, Chief Accnt Officr. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AKBA | BUY | 2014-12-01 | $13K | — | Filing → |
| AKBA | BUY | 2014-03-27 | $68K | — | Filing → |
| GENZ | SELL | 2010-05-26 | $24K | — | Filing → |